Back Pain

Christopher Wise, M.D., F.A.C.P. Medical College of Virginia at Virginia Commonwealth University

Definition/Key Clinical Features
Differential Diagnosis
Best Tests
Best Therapy
Best References

Definition/Key Clinical Features


back to top

Differential Diagnosis


back to top

Best Tests

Acute Back Pain Persistent Back Pain Test Comparison
  • MRI: confirms herniated disk or other osseous or soft tissue lesions; many false positives in unselected patients with nonradicular pain
    • Sensitivity: high for herniation and spinal stenosis
    • Specificity: high false positive rate in asymptomatic patients (bulge in 20%–80%, herniation in 20%–40%, spinal stenosis in 20% older than 60 yr)
  • Electromyography: useful in differentiating lumbar radiculopathy from other causes of radicular leg pain
    • Sensitivity: uncertain
    • Specificity: uncertain
  • Myelogram–CT scanning: useful in selected cases of lumbar stenosis or other selected conditions, most useful in selected cases for planning surgery
    • Sensitivity: similar to MRI
    • Specificity: similar to MRI
Red Flags
  • Indications that acute back pain may involve serious underlying conditions
    • Patient demographics
    • Age > 70 yr
    • History of cancer
    • Glucocorticoid therapy or immunosuppressive drug therapy
    • Alcohol or I.V. drug use
  • Historical features
    • Weight loss
    • Fever
    • Pain increased by rest
  • Neurologic symptoms
    • Bowel or bladder dysfunction
    • Saddle-block anesthesia
    • Progressive motor weakness

back to top

Best Therapy

Acute Back Pain

  • Avoid strict bed rest (at most 2–4 days)
  • Continue normal activities within limits permitted by pain
  • Mild analgesics and NSAIDs
  • Use muscle relaxants and opiates sparingly
  • Further studies (MRI, CT) indicated in patients with persistent sciatica or progressive pain
  • Surgery indicated in patients with radicular symptoms and clear-cut evidence of herniated disk correlating with symptoms
Persistent Back Pain
  • Physical therapy with local modalities, exercise program, patient-education program emphasizing proper ergonomics for lifting and other activities
  • Encourage light normal activity and regular walking program
  • Use analgesics, NSAIDs, and TCAs judiciously
  • Consider further studies (MRI, CT) and consider surgical decompression by multilevel laminectomy and fusion for patients with herniated disk or spinal stenosis and progressive functional deterioration
Analgesics and NSAIDs Comparison
  • Nonopiate analgesics: safest options; moderate efficacy
    • Acetaminophen
      • Dose: 650–1,000 mg t.i.d.–q.i.d.
    • Tramadol
      • Dose: 50–100 mg q.i.d.
      • Cost/mo: $70 (50 mg)
  • Nonselective COX inhibitors: caution with renal disease, cardiovascular disease, edema, risk factors for peptic ulcer disease; moderate efficacy
    • Ibuprofen
        Dose: 400–800 mg t.i.d.
      • Cost/mo: $10 (800 mg)
    • Naproxen
      • Dose: 500 mg b.i.d.
      • Cost/mo: $20
    • Diclofenac
      • Dose: 75 mg b.i.d.
      • Cost/mo: $30
  • COX-2 specific inhibitor: safer than nonselective COX inhibitors regarding GI risk; used with caution with renal disease, cardiovascular disease, edema; moderate efficacy
    • Celecoxib (Celebrex)
      • Dose: 200 mg b.i.d.
      • Cost/mo: $150
  • Opiates: may cause constipation, sedation; potentially habit forming, use sparingly; most used in combination form with acetaminophen; moderate efficacy
    • Propoxyphene
      • Dose: 100 mg q.i.d.
      • Cost/mo: $30
    • Codeine
      • Dose: 30 mg q.i.d.
      • Cost/mo: $30
    • Hydrocodone
      • Dose: 10 mg q.i.d.
      • Cost/mo: $60
    • Oxycodone
      • Dose: 5 mg q.i.d.
      • Cost/mo: price not available
Muscle Relaxants Comparison
  • Muscle relaxants: may cause drowsiness, dizziness; use for limited time in most patients (1–2 wk); mild to moderate efficacy
    • Carisoprodol
      • Dose: 350 mg t.i.d.–q.i.d.
      • Cost/mo: $30 (t.i.d.)
    • Cyclobenzaprine
      • Dose: 10 mg t.i.d.
      • Cost/mo: $15
    • Methocarbamol
      • Dose: 1,500 mg q.i.d.
      • Cost/mo: $20
    • Chlorzoxazone
      • Dose: 500 mg q.i.d.
      • Cost/mo: $40
    • Metaxalone
      • Dose: 800 mg q.i.d.
      • Cost/mo: $215
    • Tizanadine
      • Dose: 8 mg t.i.d.
      • Cost/mo: $160
TCA Comparison
  • TCAs: More appropriate for chronic pain; caution regarding drowsiness, urinary retention, orthostatic hypotension, dry mouth; moderate efficacy
    • Amitriptyline
      • Dose: 10–100 mg q.h.s.
      • Cost/mo: $10
    • Nortriptyline
      • Dose: 10–100 mg q.h.s.
      • Cost/mo: $10
    • Desipramine
      • Dose: 10–100 mg q.h.s.
      • Cost/mo: $10
    • Doxepin
      • Dose: 10–100 mg q.h.s.
      • Cost/mo: $9
    • Imipramine
      • Dose: 10–100 mg q.h.s.
      • Cost/mo: $20

    Best References

    Amundsen T, et al: Spine 25:1424, 2000 [PMID 10828926]

    Green S, et al: BMJ 316:354, 1998 [PMID 9487172]

    Mannion AF, et al: Rheumatology (Oxford) 40:772, 2001 [PMID 11477282]

    August 2006